TY  - GEN
AU  - Gojo,I
AU  - Karp,J E
TI  - The impact of biology on the treatment of secondary AML
SN  - 0927-3042
PY  - 2002///0520
KW  - Acute Disease
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Animals
KW  - Antineoplastic Agents
KW  - Antineoplastic Agents, Alkylating
KW  - adverse effects
KW  - Chromosome Deletion
KW  - Chromosomes, Human, Pair 11
KW  - genetics
KW  - Chromosomes, Human, Pair 7
KW  - DNA Methylation
KW  - DNA-Binding Proteins
KW  - Enzyme Inhibitors
KW  - Forecasting
KW  - Genes, Tumor Suppressor
KW  - Hematopoietic Stem Cells
KW  - drug effects
KW  - Histone Deacetylase Inhibitors
KW  - Histone-Lysine N-Methyltransferase
KW  - Humans
KW  - Leukemia, Experimental
KW  - etiology
KW  - Leukemia, Myeloid
KW  - chemically induced
KW  - Leukemia, Radiation-Induced
KW  - pathology
KW  - Mice
KW  - Mice, Inbred NOD
KW  - Mice, SCID
KW  - Myeloid-Lymphoid Leukemia Protein
KW  - Neoplasm Proteins
KW  - antagonists & inhibitors
KW  - Neoplasms
KW  - drug therapy
KW  - Neoplasms, Second Primary
KW  - Neoplastic Stem Cells
KW  - Neovascularization, Pathologic
KW  - Oncogene Proteins, Fusion
KW  - Proto-Oncogenes
KW  - Stromal Cells
KW  - Topoisomerase II Inhibitors
KW  - Transcription Factors
KW  - Translocation, Genetic
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/978-1-4615-1463-3_12
ER  -